Pure Global
NCT06321276

Investigation of the Efficiency of Radial Extracorporeal Shock Wave Therapy at Different Pulses in Carpal Tunnel Syndrome

Investigation of the Efficiency of Radial Extracorporeal Shock Wave Therapy at Different Pulses in Patients With Carpal Tunnel Syndrom a Randomized Controlled Study
Ahi Evran University Education and Research Hospital·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Carpal Tunnel Syndrome
Drug/Device/Intervention
extracorporeal shockwave therapy
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Ahi Evran University Education and Research Hospital
Location
Kırşehir, Turkey
Timeline & enrollment
Phase
N/A
Start date
Mar 18, 2024
End date
Jun 01, 2024
Enrollment
90 participants
Primary outcome

Visual analogue scale (VAS),Boston Carpal Tunnel Syndrome Questionnaire

Summary

Different parameters have been used in studies investigating the efficacy of extracorporeal
 shock wave therapy in the treatment of carpal tunnel syndrome. Although extracorporeal shock
 wave therapy has been shown to have a positive effect on carpal tunnel syndrome, there is no
 consensus on which pulse rate is more effective. Therefore, in this study, the efficacy of
 extracorporeal shock wave therapy applied at different pulse rates in the treatment of carpal
 tunnel syndrome will be examined.

ICD-10 classifications
Carpal tunnel syndromeTarsal tunnel syndromeArthrosis of first carpometacarpal joint, unspecifiedArthrosis of first carpometacarpal jointOther specified disorders of synovium and tendon
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06321276
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06321276 through Pure Global AI's free database. This phase not specified trial is sponsored by Ahi Evran University Education and Research Hospital and is currently Recruiting. The study focuses on Carpal Tunnel Syndrome. Target enrollment is 90 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.